STERIS’ (TSE:STE – Get Free Report) was upgraded by investment analysts at Cormark to a “moderate buy” rating in a report released on Monday,Zacks.com reports.
Separately, Atb Cap Markets upgraded STERIS’ to a “strong-buy” rating in a research report on Sunday, December 22nd.
Check Out Our Latest Report on STE
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- 10 Best Airline Stocks to Buy
- Top 2 Auto Maintenance Stocks Gearing Up for 2025
- What is a Secondary Public Offering? What Investors Need to Know
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
- How Can Investors Benefit From After-Hours Trading
- The 5 Stocks Congress Bought Most in 2024: Top Picks for 2025
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
